TherapeuticsmdTXMD

13F holders, Q4 2024 (December 31)
41holders +4
6new positions
4sold out
2famous investors
$0.86avg. 13F price*

At the end of Q4 2024, 41 institutions reported holding Therapeuticsmd Inc. (TXMD) in their 13F filings, up 4 from Q3 2024. 6 opened new positions and 4 sold out. The largest holders were Rubric Capital Management LP ($1.0M), Clearline Capital LP ($546K) and Tejara Capital Ltd ($339K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Therapeuticsmd Inc.
CUSIP
88338N206
Latest filing quarter
Q2 2026

History

Number of 13F holders

01020304050 Q1 2024: 43Q1 2024Q2 2024: 38Q2 2024Q3 2024: 37Q3 2024Q4 2024: 41Q4 2024Q1 2025: 42Q1 2025Q2 2025: 42Q2 2025Q3 2025: 46Q3 2025Q4 2025: 44Q4 2025Q1 2026: 49Q1 2026Q2 2026: 44Q2 2026

Total Exit/New Position Q3 2024 → Q4 2024

InstitutionsTotal Value
New Positions6$136K
Exits4$1K

All 13F filers, Q3 2024 → Q4 2024: 161,298 shares bought and 11,831 shares sold, net +149,467 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 41 holders

Rubric Capital Management LP 0.02% No change 1,192,191 $1.0M
Clearline Capital LP 0.07% Reduce -0.2% 635,222 $546K
Tejara Capital Ltd 0.22% Reduce -1.7% 394,661 $339K
Vanguard Group Inc. 0.00% No change 387,582 $333K
ADAR1 Capital Management, LLC 0.05% No change 270,160 $232K
Citadel Advisors 0.00% New 145,802 $125K
Morgan Stanley 0.00% Add +0.5% 132,389 $114K
BlackRock, Inc. 0.00% No change 116,132 $100K
Geode Capital Management, LLC 0.00% No change 108,333 $93K
Bridgeway Capital Management, LLC 0.00% No change 34,000 $29K
State Street Corp. 0.00% No change 30,100 $26K
Ameriprise Financial Inc. 0.00% No change 22,470 $19K
Northern Trust Corp. 0.00% No change 16,457 $14K
J. Goldman & Co LP 0.00% No change 13,562 $12K
Renaissance Technologies 0.00% New 10,891 $9K
FMR LLC 0.00% No change 8,289 $7K
Tower Research Capital LLC (TRC) 0.00% Add +110.4% 4,776 $4K
UBS Group AG 0.00% Reduce -58.5% 2,012 $2K
Group One Trading LLC 0.00% New 1,135 $976
National Bank of Canada 0.00% No change 610 $525
Bank of America Corp. 0.00% No change 494 $425
JPMorgan Chase & Co. 0.00% Add +7.5% 315 $271
SBI Securities Co., Ltd. 0.00% — 255 $219
US Bancorp \de 0.00% No change 246 $212
BNP Paribas Financial Markets 0.00% New 224 $193
Huntington National Bank 0.00% No change 120 $103
Wells Fargo & Company 0.00% Reduce -32.6% 97 $83
IFP Advisors, Inc 0.00% No change 80 $69
Activest Wealth Management 0.00% No change 40 $34
Atlatl Advisers LLC 0.00% — 40 $34
Osaic Holdings, Inc. 0.00% Reduce -64.3% 20 $17
Provenance Wealth Advisors, LLC 0.00% No change 20 $17
Harbour Investments, Inc. 0.00% No change 8 $7
Assetmark, Inc. 0.00% No change 4 $3
NewEdge Advisors, LLC 0.00% New 3 $3
Northwestern Mutual Wealth Management Co. 0.00% New 2 $2
Guardian Wealth Management, Inc. 0.00% No change 2 $2
EverSource Wealth Advisors, LLC 0.00% No change 1 $1
Royal Bank of Canada 0.00% No change 154 $0
Simplex Trading, LLC 0.00% Add +2150.0% 45 $0
Tsfg, LLC 0.00% No change 64 $0

"% of holder's portfolio" is TXMD's weight in each manager's 13F, not the share of Therapeuticsmd Inc. the manager owns.